BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24311640)

  • 1. Assessment of prognostic scores in brain metastases from breast cancer.
    Tabouret E; Metellus P; Gonçalves A; Esterni B; Charaffe-Jauffret E; Viens P; Tallet A
    Neuro Oncol; 2014 Mar; 16(3):421-8. PubMed ID: 24311640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer patients with brain metastases or leptomeningeal disease: 10-year results of a national cohort with validation of prognostic indexes.
    Znidaric T; Gugic J; Marinko T; Gojkovic Horvat A; Paulin Kosir MS; Golo D; Ivanetic Pantar M; Ratosa I
    Breast J; 2019 Nov; 25(6):1117-1125. PubMed ID: 31286623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: extra-cranial disease progression is an independent risk factor.
    Zhuang Q; Wong RX; Lian WX; Li YQ; Wong FY
    Ann Palliat Med; 2019 Sep; 8(4):390-400. PubMed ID: 30943738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival outcomes of breast cancer patients with brain metastases: A multicenter retrospective study in Korea (KROG 16-12).
    Kim JS; Kim K; Jung W; Shin KH; Im SA; Kim HJ; Kim YB; Chang JS; Choi DH; Park YH; Kim DY; Kim TH; Choi BO; Lee SW; Kim S; Kwon J; Kang KM; Chung WK; Kim KS; Nam JH; Yoon WS; Kim JH; Cha J; Oh YK; Kim IA
    Breast; 2020 Feb; 49():41-47. PubMed ID: 31677532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: A multicentric European experience.
    Griguolo G; Jacot W; Kantelhardt E; Dieci MV; Bourgier C; Thomssen C; Bailleux C; Miglietta F; Braccini AL; Conte P; Ferrero JM; Guarneri V; Darlix A
    Breast; 2018 Feb; 37():36-41. PubMed ID: 29073498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of outcomes for patients with brain parenchymal metastases from breast cancer (BC): a new BC-specific prognostic model and a nomogram.
    Ahn HK; Lee S; Park YH; Sohn JH; Jo JC; Ahn JH; Jung KH; Park S; Cho EY; Lee JI; Park W; Choi DH; Huh SJ; Ahn JS; Kim SB; Im YH
    Neuro Oncol; 2012 Aug; 14(8):1105-13. PubMed ID: 22693244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative performances of prognostic indexes for breast cancer patients presenting with brain metastases.
    Braccini AL; Azria D; Thezenas S; Romieu G; Ferreri JM; Jacot W
    BMC Cancer; 2013 Feb; 13():70. PubMed ID: 23394467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases.
    Darlix A; Hirtz C; Thezenas S; Maceski A; Gabelle A; Lopez-Crapez E; De Forges H; Firmin N; Guiu S; Jacot W; Lehmann S
    BMC Cancer; 2019 Jan; 19(1):110. PubMed ID: 30700265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer brain metastases - A 12 year review of treatment outcomes.
    De Ieso PB; Schick U; Rosenfelder N; Mohammed K; Ross GM
    Breast; 2015 Aug; 24(4):426-33. PubMed ID: 25881974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum NSE, MMP-9 and HER2 extracellular domain are associated with brain metastases in metastatic breast cancer patients: predictive biomarkers for brain metastases?
    Darlix A; Lamy PJ; Lopez-Crapez E; Braccini AL; Firmin N; Romieu G; Thézenas S; Jacot W
    Int J Cancer; 2016 Nov; 139(10):2299-311. PubMed ID: 27464303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of nine prognostic scores in patients with brain metastases of breast cancer receiving radiotherapy of the brain.
    Laakmann E; Riecke K; Goy Y; Kersten JF; Krüll A; Müller V; Petersen C; Witzel I
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):325-32. PubMed ID: 26424693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer.
    Pietrantonio F; Aprile G; Rimassa L; Franco P; Lonardi S; Cremolini C; Biondani P; Sbicego EL; Pasqualetti F; Tomasello G; Niger M; Casagrande M; Ghidini M; Muni R; Montrone S; Bergamo F; Berenato R; Fontanella C; Bozzarelli S; Moretto R; Battaglin F; Di Bartolomeo M; de Braud F; Miceli R
    Radiother Oncol; 2015 Nov; 117(2):315-21. PubMed ID: 26347495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Overweight, Obesity, and Comorbidities in the Prognosis of Patients With Breast Cancer With Brain Metastases.
    Cacho-Díaz B; Spínola-Maroño H; Reynoso N; González-Aguilar A; Mohar-Betancourt A
    Clin Breast Cancer; 2019 Apr; 19(2):e394-e398. PubMed ID: 30745110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcome of patients with brain metastases from breast cancer - A population based study over 21 years.
    Thulin A; Rönnerman E; Zhang C; De Lara S; Chamalidou C; Schoenfeldt A; Andersson C; Kovács A; Enlund F; Linderholm B
    Breast; 2020 Apr; 50():113-124. PubMed ID: 32145571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond breast specific-Graded Prognostic Assessment in patients with brain metastases from breast cancer: treatment impact on outcome.
    Griguolo G; Dieci MV; Giarratano T; Giorgi CA; Orvieto E; Ghiotto C; Berti F; Della Puppa A; Falci C; Mioranza E; Tasca G; Milite N; Miglietta F; Scienza R; Conte P; Guarneri V
    J Neurooncol; 2017 Jan; 131(2):369-376. PubMed ID: 27853958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and Prognostic Factors for Patients With HER2-overexpressing Breast Cancer and Brain Metastases in the Era of HER2-targeted Therapy: An Argument for Earlier Detection.
    Morikawa A; Wang R; Patil S; Diab A; Yang J; Hudis CA; McArthur HL; Beal K; Seidman AD
    Clin Breast Cancer; 2018 Oct; 18(5):353-361. PubMed ID: 29337140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of prognostic scores of brain metastases from lung adenocarcinoma with EGFR mutations.
    Li H; Lian J; Jin H; Wang W; Cao J; Zhang X; Song X; Jia S; Jia H; Ren J; Han S; Yang W; Xi Y; Lan S
    J Neurooncol; 2017 May; 133(1):129-135. PubMed ID: 28391386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases.
    Anders CK; Deal AM; Miller CR; Khorram C; Meng H; Burrows E; Livasy C; Fritchie K; Ewend MG; Perou CM; Carey LA
    Cancer; 2011 Apr; 117(8):1602-11. PubMed ID: 21472708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain metastases from breast cancer.
    Santos J; Arantes J; Carneiro E; Ferreira D; Silva SM; Palma de Sousa S; Arantes M
    Clin Neurol Neurosurg; 2020 Oct; 197():106150. PubMed ID: 32920499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic scores in brain metastases from breast cancer.
    Nieder C; Marienhagen K; Astner ST; Molls M
    BMC Cancer; 2009 Apr; 9():105. PubMed ID: 19351389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.